MARKET

BIOA

BIOA

BioAge Labs Inc.
NASDAQ
4.070
+0.030
+0.74%
After Hours: 4.030 -0.04 -0.98% 17:12 05/12 EDT
OPEN
4.180
PREV CLOSE
4.040
HIGH
4.190
LOW
4.000
VOLUME
129.78K
TURNOVER
--
52 WEEK HIGH
26.62
52 WEEK LOW
2.880
MARKET CAP
145.90M
P/E (TTM)
-2.0519
1D
5D
1M
3M
1Y
5Y
1D
Cautious Outlook on BioAge Labs, Inc. Amid Program Setbacks and Financial Concerns
TipRanks · 1d ago
BioAge Labs Advances Pipeline with Strategic Collaborations
TipRanks · 4d ago
BioAge Labs reports Q1 results
Seeking Alpha · 5d ago
BIOAGE LABS INC <BIOA.O>: JEFFERIES CUTS TARGET PRICE TO $4 FROM $7
Reuters · 5d ago
Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Immutep Ltd (OtherPRRUF)
TipRanks · 6d ago
BIOAGE LABS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
Reuters · 6d ago
Weekly Report: what happened at BIOA last week (0428-0502)?
Weekly Report · 05/05 12:37
Weekly Report: what happened at BIOA last week (0421-0425)?
Weekly Report · 04/28 12:53
More
About BIOA
More
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its lead product is BGE-102, a structurally novel, orally available small molecule NLRP3 inhibitor with high potency and brain penetration. In preclinical obesity models, BGE-102 resulted in weight loss as both a monotherapy and in combination with a GLP-1R agonist. Its pipeline includes novel, orally available, brain-penetrant small-molecule NLRP3 inhibitors to treat metabolic diseases and conditions driven by neuroinflammation, as well as novel APJ agonists for metabolic disorders. In preclinical obesity models, APJ agonism has demonstrated the ability to more than double the weight loss induced by a GLP-1R agonist while also restoring healthy body composition and improving muscle function.
Recently
Symbol
Price
%Change
    EFX
  • 276.37
  • +2.39%

Webull offers BioAge Labs, Inc. stock information, including NASDAQ: BIOA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIOA stock methods without spending real money on the virtual paper trading platform.